A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: Toxicity of a three- versus a four-week schedule
Authors:
- Ana BarrosoABAna Barroso
- Sara CondeSCSara Conde
- T[Acirc ]Nia Guimar[Atilde]EsTGT[Acirc ]Nia Guimar[Atilde]Es
- Jorge SeadaJSJorge Seada
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Seminars in Oncology
- Vol. 28 (3H) , 10-14